Hoat Huyet Nhat Nhat Versus Tanakan for Treatment of Symptoms Related to the Insufficient Blood Supply to the Brain

Nhat Nhat Pharmaceutical Company750 enrolled

Overview

The purpose of this study is to evaluate the effectiveness of Hoat Huyet Nhat Nhat on the reduction of common symptoms related to the insufficient blood supply to the brain such as headache, vertigo, dizziness, sleep disorders and forgetfulness; compared with Gingko Biloba Egb761 (Tanakan) after 45 days of treatment

Study Type

OBSERVATIONAL

Enrollment

750

Conditions

Insufficient Blood Supply to the Brain

Interventions

Hoat Huyet Nhat NhatDRUG

Administered orally twice a day, 2 tablets each time, for 45 days.

Tanakan 40mgDRUG

Administered orally three times a day, 1 tablet each time, for 45 days.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Male and Female more than 18 year old. * With at least one of the symptoms related to the insufficient blood supply to the brain scored more than 5 out 10, on the Visual Analog Scale. * Patients who will be using either Hoat Huyet Nhat Nhat or Tanakan following doctor's prescription or by patients own decision. * Sign the informed consent form Exclusion Criteria: * Use of any medications for treatment of the insufficient blood supply to the brain in the last 3 months

Locations (1)

Vietnam Military Medical University

Hanoi, Vietnam

Outcomes

Primary Outcomes

The percentage of patients with symptoms related to the insufficient blood supply to the brain recovered after 45 days of treatment as assessed by Symptom Improvement Likert Scale in Hoat Huyet Nhat Nhat and Tanakan 40mg group

Time frame: 45 days

Secondary Outcomes

Change From Baseline to 45 days of the severity of headache symptom in patients with symptoms related to the insufficient blood supply to the brain as assessed by Visual Analog Scale (VAS)

Time frame: 45 days

Change From Baseline to 45 days of the severity of vertigo symptom in patients with symptoms related to the insufficient blood supply to the brain as assessed by Visual Analog Scale (VAS)

Time frame: 45 days

Change From Baseline to 45 days of the severity of dizziness symptom in patients with symptoms related to the insufficient blood supply to the brain as assessed by Visual Analog Scale (VAS)

Time frame: 45 days

Change From Baseline to 45 days of the severity of sleep disorders symptom in patients with symptoms related to the insufficient blood supply to the brain as assessed by Visual Analog Scale (VAS)

Time frame: 45 days

Change From Baseline to 45 days of the severity of forgetfulness symptom in patients with symptoms related to the insufficient blood supply to the brain as assessed by Visual Analog Scale (VAS)

Time frame: 45 days

Change From Baseline to 45 days of the severity of all symptoms related to the insufficient blood supply to the brain as assessed by Khadjev Score

Time frame: 45 days

The number of participants with clinically significant vital sign parameters at Day 45.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.